Hanmi Pharmaceutical Company Limited: all 189 studies

Page 2 of 2. Open to participants first (10), then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate Efficacy and Safety of HCP1401 for Stage 2 Hypertension Patients Not Controlled by HCP0605CompletedNCT02916602Phase 3
• Clinical Efficacy and Safety Evaluation of Co-administered HGP0904, HGP0608 and HGP0816 in Patients With Hypertension and DyslipidemiaCompletedNCT02899455Phase 3
• PK and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 Under Fed Condition in Healthy Male VolunteersCompletedNCT02715401Phase 1
• Pharmacokinetics and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 in Healthy Male VolunteersCompletedNCT02712411Phase 1
• A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 CapsulesCompletedNCT02667938Phase 3
• Trial to Evaluate the Efficacy and Safety of HCP1302CompletedNCT02587988Phase 3
• Evaluating a Pharmacokinetic Drug Interaction Between HGP0918 and HGP0816CompletedNCT02554136Phase 1
• Efficacy and Safety of HCP1102 CapsuleCompletedNCT02552667Phase 3
• Evaluating the Efficacy and Safety of HCP1105 in Combined Hyperlipidemic Patients With High Risk for CHDStatus unknownNCT02551172Phase 3
• Evaluating the Bioequivalence of HIP1302, HGP1406CompletedNCT02545829Phase 1
• Investigating the Pharmacokinetic Characteristics of HIP1402 in Healthy Male VolunteersCompletedNCT02529800Phase 1
• Study to Evaluate the Non-inferiority of Cavir in HBeAg(+)Chronic Hepatitis B Patients Treated With BaracludeStatus unknownNCT02523547Phase 4
• Phase II Trial of HM61713 for the Treatment of ≥2nd Line T790M Mutation Positive Adenocarcinoma of the LungTerminatedNCT02485652Phase 2
• Evaluating the Bioequivalence of HIP1403, HGP0919CompletedNCT02473900Phase 1
• Phase II Trial to Evaluate the Efficacy and Safety of HM61713 as the 1st-line NSCLC Anticancer TherapyCompletedNCT02444819Phase 2
• Poziotinib in Patients With HER2+ Recurrent Stage IV BC Who Have Received at Least 2 Prior HER2-directed RegimensCompletedNCT02418689Phase 2
• Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetics and Anti-tumor Activity of HM95573CompletedNCT02405065Phase 1
• A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPHCompletedNCT02390882Phase 3
• A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12470CompletedNCT02302443Phase 1
• Investigating the Pharmacokinetic Drug Interactions Between HGP1201 and HGP0904CompletedNCT02243319Phase 1
• Evaluating a Pharmacokinetic Drug Interaction Between Tadalafil and TamsulosinCompletedNCT02239484Phase 1
• Efficacy/Safety of HCP1306 Tablet Versus HGP0816 Tablet in Patients With Primary HypercholesterolemiaCompletedNCT02205606Phase 3
• Evaluating a Pharmacokinetic Drug Interaction Between Amlodipine/Losartan and RosuvastatinStatus unknownNCT02140489Phase 1
• Investigating the Pharmacokinetic Drug Interactions Between Rosuvastatin and EzetimibeCompletedNCT02127320Phase 1
• Glycaemic Control of Monthly LAPS-Exendin Versus Placebo in Subjects of Type 2 DiabetesCompletedNCT02081118Phase 2
• Effect of LAPS-Exendin on Body Weight in Obese PopulationCompletedNCT02075281Phase 2
• A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes MellitusStatus unknownNCT02059564Phase 1
• Safety,Tolerability and Pharmacokinetic Study of Recombinant Human Interferon Alfa 2B in Chronic Hepatitis C Patients (HM10660A)Status unknownNCT02057887Phase 1/2
• Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 DiabetesCompletedNCT02057172Phase 2
• Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 10mgCompletedNCT02026817Phase 1
• Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 500mg and Rosuvastatin 10mgCompletedNCT02011633Phase 1
• Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 20mgCompletedNCT01929512Phase 1
• A Pilot Study to Evaluate the Pharmacokinetics of Omega-3 Between Rosuvastatin and Omega-3 Coadministration and HCP1007CompletedNCT01929070Phase 1
• Safety and Efficacy Study of HGP1207 in Patients With Pulmonary HypertensionStatus unknownNCT01913847Phase 3
• Single-dose, 2-way Crossover Open Study to Evaluate the Food Effect on the PK of HCP1201 in Healthy VolunteersCompletedNCT01901757Phase 1
• Study to Evaluate a Pharmacokinetic of HM61713 in Healthy Male SubjectsCompletedNCT01894399Phase 1
• Efficacy and Safety Study of ALS-L1023 in Patients With Abdominal Obesity of Metabolic SyndromeTerminatedNCT01872182Phase 3
• Partial Replicated Crossover Clinical Study to Compare Pharmacokinectic Characteristics of Eperisone Hydrochloride and Aceclofenac With HCP1104 Treatment to Those of Co-administration of Eperisone Hydrochloride 50mg Tablet and Aceclofenac 100mg Tablet in Healthy Adult Male VolunteersCompletedNCT01869985Phase 1
• To Compare the Pharmacokinetics of Traclear 62.5 mg Tablets and HGP1206 125mg 1 Tablet in Healthy Male VolunteersCompletedNCT01864863Phase 1
• Diurnal Variation in Hypertensive Stroke PatientsCompletedNCT01830517Phase 4
• Comparison of Effect & Safety of Clopidogrel Napadisilate With Clopidogrel Bisulfate in Coronary Artery Disease PatientsCompletedNCT01830491Phase 4
• The Efficacy and Safety Study of Anti-hypertension Combination Drug in Patients Uncontrolled With Monotherapy.CompletedNCT01828359Phase 4
• Safety and Efficacy Study of Recombinant Human Growth Hormone in Adult Growth Hormone Deficiency PatientsCompletedNCT01822340Phase 2
• Comparing Efficacy and Safety Between Eperisone a BID and a TID Regimen in Acute Low Back Pain PatientsCompletedNCT01806818Phase 2
• Evaluating a Pharmacokinetic Drug Interaction Between Metformin Hydrochloride and Rosuvastatin CalciumCompletedNCT01775579Phase 1
• Safety,PK/PD, Food Effect Study of Orally Administered HM71224 in Healthy Adult Male VolunteersCompletedNCT01765478Phase 1
• A Study of KX2-391 With Paclitaxel in Patients With Solid TumorsStatus unknownNCT01764087Phase 1/2
• A Phase I-II Study of HM781-36B Combined With Paclitaxel and Trastuzumab in HER-2 Positive Advanced Gastric CancerCompletedNCT01746771Phase 1/2
• A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12460ACompletedNCT01724814Phase 1
• Study to Evaluate and Compare Safety and Pharmacokinetics of the HCP1004 and VIMOVO 500/20mg in Healthy Korean MaleCompletedNCT01688193
• Study to Evaluate the Pharmacokinetics and Safety of Singulair and Xyzal in Free Combination and Fixed-dose CombinationCompletedNCT01651481Phase 1
• Efficacy and Safety of Concomitant Montelukast Sodium and Levocetirizine Dihydrochloride in Perennial Allergic Rhinitis (PAR) PatientsCompletedNCT01640535Phase 3
• Study to Evaluate a Pharmacokinetic Drug Interaction Between Eperisone Hydrochloride and Aceclofenac in Healthy Male SubjectsCompletedNCT01638286
• Phase I/II Trial to Evaluate Safety, Tolerability and Pharmacokinetic Profile of HM61713 in NSCLC PatientsCompletedNCT01588145Phase 1/2
• A Drug-Drug Interaction Study of Ambroxol and LevodropropizineCompletedNCT01573663Phase 1
• Efficacy and Safety of Simvast Controlled Release (CR) and Zocor in Chronic Kidney Disease(CKD) Stage 3, 4 and 5 Patients With HyperlipidemiaStatus unknownNCT01564875Phase 4
• Clinical Trial to Evaluate the Effect of Food on the Pharmacokinetic Characteristics of HIP0901 CapsuleCompletedNCT01555398Phase 1
• Clinical Trial to Evaluate the Effect on the Pharmacokinetic Characteristics of HCP1007 CapsuleCompletedNCT01548157Phase 1
• Therapeutic Equivalence Study of HCP0910 250/50 Mcg to Seretide 250 Diskus in Asthmatic PatientsCompletedNCT01521455Phase 1
• Pharmacokinetics of Sildenafil Following Administration of an Chewable Tablet of Sildenafil Relative to Viagra® Conventional Oral Tablet in Healthy VolunteersCompletedNCT01514903Phase 1
• Efficacy/Safety of Pseudoephedrine Plus Levocetirizine Versus Placebo in Patients With Vasomotor RhinitisCompletedNCT01509209Phase 3
• A Bioequivalence Study Comparing HIP0901 Capsule With Lipidilsupra TabletCompletedNCT01509196Phase 1
• Exploratory Clinical Study to Evaluate the Optimal Dosage of Mosapride and Probiotics in Irritable Bowel Syndrome Without Predominant DiarrheaCompletedNCT01505777Phase 2
• Safety, Pharmacokinetic, Pharmacodynamic Study of LAPS-IFNa in Healthy Adult SubjectsCompletedNCT01504581Phase 1
• A Drug Interaction Study of Montelukast and LevocetirizineCompletedNCT01491503Phase 1
• A Study of Oraxol® in Gastric Cancer PatientsStatus unknownNCT01491217Phase 1/2
• Clinical Trial to Determine the Maximum Tolerated Dose and to Assess the Safety and Pharmacokinetic Profile of Oral Paclitaxel in Patients With Advanced Solid CancerCompletedNCT01491204Phase 1
• Clinical Trial to Determine the MTD of HM781-36B in Patients With Advanced Solid TumorsCompletedNCT01455584Phase 1
• Phase I Study to Determine the Maximum Tolerated Dose and to Assess the Safety and Pharmacokinetic Profile of HM781-36B in Patients With Advanced Solid TumorsCompletedNCT01455571Phase 1
• Safety, Tolerability, Pharmacokinetics,Pharmacodynamics Study of LAPS-Exendin in Subjects of Type 2 Diabetes MellitusCompletedNCT01452451Phase 2
• A Bioequivalence Study Comparing Clopidogrel/Aspirin Combination Tablet With Coadministration of Clopidogrel and AspirinCompletedNCT01448330Phase 1
• A Bioequivalence Study Comparing Irbesartan/Atorvastatin Combination Tablet With Coadministration of Irbesartan and AtorvastatinCompletedNCT01447797Phase 1
• Efficacy and Safety of Irbesartan and Atorvastatin in Hypertension and HyperlipidemiaCompletedNCT01442987Phase 3
• A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and LosartanCompletedNCT01197014Phase 1
• A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and LosartanCompletedNCT01197001Phase 1
• Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Stage 2 HypertensionCompletedNCT01127217Phase 3
• A Study of HM10560A in Healthy Male SubjectCompletedNCT01093742Phase 1
• A Study of HM11260C in Healthy Male SubjectCompletedNCT01093729Phase 1
• Safety and PK of HM10460A (HNK460) in Healthy Adult Japanese and Caucasian SubjectsCompletedNCT01037543Phase 1
• A Study of HM10760A (Long-acting Erythropoietin) in Healthy Adult Caucasian and Japanese SubjectsCompletedNCT01030315Phase 1
• A Study of HM10760A (Long-acting Erythropoietin (EPO)) in Healthy Korean SubjectsCompletedNCT01013064Phase 1
• Assess the Safety, Tolerability, and Pharmacokinetic (PK) Characteristics of HM10460A (HNK460) in Healthy Adult Korean SubjectsCompletedNCT00998283Phase 1
• Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid Malignancies (Oratecan-102)CompletedNCT00986843Phase 1
• Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid MalignanciesCompletedNCT00979563Phase 1
• Efficacy and Safety of Morning Versus Evening Intake of Simvast Controlled Release (CR) Tablet in Patients With HyperlipidemiaCompletedNCT00973115Phase 3
• Duration of P-glycoprotein Inhibition After Oral Administration of HM30181AK TabletCompletedNCT00954304Phase 1
• Efficacy and Safety of Amlodipine and Losartan in Patients With Essential HypertensionCompletedNCT00942344Phase 2
• Efficacy/Safety of Amlodipine Plus Losartan Versus Losartan in Patients With Essential HypertensionCompletedNCT00940680Phase 3
• Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Essential HypertensionCompletedNCT00940667Phase 3

← Hanmi Pharmaceutical Company Limited overview and focus areas